Taro Pharmaceutical Industries Ltd. (TARO)
NYSE: TARO · IEX Real-Time Price · USD
42.45
-0.06 (-0.14%)
May 3, 2024, 4:00 PM EDT - Market closed
TARO Employees
Taro Pharmaceutical Industries had 1,554 employees on March 31, 2023. The number of employees increased by 99 or 6.80% compared to the previous year.
Employees
1,554
Change (1Y)
99
Growth (1Y)
6.80%
Revenue / Employee
$393,068
Profits / Employee
$29,409
Market Cap
1.60B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2023 | 1,554 | 99 | 6.80% |
Mar 31, 2022 | 1,455 | 38 | 2.68% |
Mar 31, 2021 | 1,417 | -47 | -3.21% |
Mar 31, 2020 | 1,464 | 0 | - |
Mar 31, 2019 | 1,464 | -26 | -1.74% |
Mar 31, 2018 | 1,490 | 77 | 5.45% |
Mar 31, 2017 | 1,413 | 6 | 0.43% |
Mar 31, 2016 | 1,407 | 68 | 5.08% |
Mar 31, 2015 | 1,339 | -3 | -0.22% |
Mar 31, 2014 | 1,342 | 48 | 3.71% |
Mar 31, 2013 | 1,294 | 21 | 1.65% |
Mar 31, 2012 | 1,273 | 75 | 6.26% |
Dec 31, 2011 | 1,198 | 49 | 4.26% |
Dec 31, 2010 | 1,149 | -49 | -4.09% |
Dec 31, 2009 | 1,198 | 68 | 6.02% |
Dec 31, 2008 | 1,130 | 0 | - |
Dec 31, 2007 | 0 | -1,149 | -100.00% |
Dec 31, 2006 | 1,149 | -177 | -13.35% |
Dec 31, 2005 | 1,326 | -21 | -1.56% |
Dec 31, 2004 | 1,347 | -99 | -6.85% |
Dec 31, 2003 | 1,446 | 298 | 25.96% |
Dec 31, 2002 | 1,148 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Addus HomeCare | 34,846 |
U.S. Physical Therapy | 6,720 |
Zai Lab | 2,175 |
Tilray Brands | 1,600 |
Schrödinger | 867 |
Supernus Pharmaceuticals | 652 |
Ardelyx | 267 |
Inhibrx | 172 |
TARO News
- 11 days ago - TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO - Business Wire
- 18 days ago - Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd. - Business Wire
- 3 months ago - Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro - PRNewsWire
- 3 months ago - Taro to Release Third Quarter Results on January 25, 2024 - Business Wire
- 3 months ago - TARO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Taro Pharmaceutical Industries Ltd. Is Fair to Shareholders - Business Wire
- 3 months ago - Taro Announces Merger Agreement with Sun Pharma - PRNewsWire
- 7 months ago - Taro to Release Second Quarter Results on October 26, 2023 - Business Wire
- 7 months ago - These Israeli pharmaceutical stocks are down in the wake of Hamas attack - Market Watch